Algipharma As

Omegatri As

Astrid Hilde Myrset

Jo Klaveness

Arne Dessen

Philip Rye

Trine-Lise Torgersen

A method is for the treatment of a condition in a subject, which arises from or is associated with CFTR dysfunction. The method includes administering to the subject an effective amount of a CFTR modulator together with an effective amount of an alginate oligomer. The condition can be cystic fibrosis (CF), non-compound CFTR gene mutation heterozygosity, abnormal mucus clearance in the respiratory tract and/or breathing difficulties resulting from chronic particulate inhalation, COPD, chronic bronchitis, emphysema, bronchiectasis, asthma or chronic sinusitis, or a complication of any of these.

Growing community of inventors

Oslo, Norway

Astrid Hilde Myrset